Complex variant t(9;22) chromosome translocations in five cases of chronic myeloid leukemia

Advances in Hematology

Volumn 2009, Issue , 2009, Pages

  Valencia, Ana ^a   Cervera, José ^a   Such, Esperanza ^a   Barragán, Eva ^a   Bolufer, Pascual ^a   Fuster, Oscar ^a   Collado, Rosa ^b   Martínez, Jess ^a   Sanz, Miguel A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BCR ABL FUSION GENE; CHROMOSOME 10; CHROMOSOME 22; CHROMOSOME 3; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HUMAN; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION;

EID: 77953466592     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2009/187125     Document Type: Article

References (12)

1. Faderl S., Talpaz M., Estrov Z. et al., The biology of chronic myeloid leukemia The New England Journal of Medicine 1999 341 164 172 (Pubitemid 29325745)
2. Sawyers C. L., Chronic myeloid leukemia The New England Journal of Medicine 1999 340 1330 1340
3. Huret J. L., Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia Human Genetics 1990 85 6 565 568
4. ISCN, Shaffer L. G., Tommerup N., Guidelines for Cancer Cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature 2005 Basel, Switzerland Karger
5. Bolufer P., Sanz G. F., Barragn E. et al., Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes Haematologica 2000 85 12 1248 1254 (Pubitemid 32063693)
6. Cross N. C. P., Hughes T. P., Feng L. et al., Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse British Journal of Haematology 1993 84 1 67 74 (Pubitemid 23158117)
7. Mitelman F., ISCN: Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature 1995 Basel, Switzerland Karger
8. El-Zimaity M. M. T., Kantarjian H., Talpaz M. et al., Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome British Journal of Haematology 2004 125 2 187 195 (Pubitemid 38534970)
9. Johansson B., Fioretos T., Mitelman F., Cytogenetic and molecular genetic evolution of chronic myeloid leukemia Acta Haematologica 2002 107 2 76 94 (Pubitemid 34264171)
10. Marktel S., Marin D., Foot N. et al., Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression Haematologica 2003 88 3 260 267 (Pubitemid 36358713)
11. Sinclair P. B., Nacheva E. P., Leversha M. et al., Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia Blood 2001 98 9 2879 2880 (Pubitemid 30062690)
12. Quintas-Cardama A., Kantarjian H., Talpaz M. et al., Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia Blood 2005 105 6 2281 2286 (Pubitemid 40387020)